Table 4 Total number of treatment initiations during the pre-DAA period (n = 15,063)

From: Early Treatment Uptake and Cost Burden of Hepatitis C Therapies Among Newly Diagnosed Hepatitis C Patients with a Particular Focus on HIV Coinfection

Variable HCV only (n = 14,681) % HCV/HIV (n = 382) % Total %
Untreated 10,813 73.7 311 81.4 11,124 73.8
Dual therapy 1845 12.6 48 12.6 1893 12.6
Triple therapy 2023 13.8 23 6.0 2046 13.6
All-oral therapy 0 0.0 0 0.0 0 0.0